A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Public ClinicalTrials.gov record NCT07091019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT07091019
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Interventions
- TKIs Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2025
- Primary completion
- Apr 19, 2033
- Completion
- Apr 19, 2033
- Last update posted
- Jul 19, 2026
2025 – 2033
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233-0271 | Recruiting |
| Stockton Hematology Oncology Medical Group Inc | Stockton | California | 95204 | Recruiting |
| Lundquist Inst BioMed at Harbor | Torrance | California | 90509-2910 | Recruiting |
| Stamford Hospital | Stamford | Connecticut | 06902 | Recruiting |
| Sacred Heart Medical Oncology | Pensacola | Florida | 32504 | Recruiting |
| Cancer Care Specialists of Central Illinois | Decatur | Illinois | 62526 | Recruiting |
| St Agnes Hospital | Baltimore | Maryland | 21229 | Recruiting |
| Truman Medical Center | Kansas City | Missouri | 64108 | Recruiting |
| NY Cancer and Blood Specialists | East Setauket | New York | 11733 | Recruiting |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | Recruiting |
| Tri-County Hematology and Oncology Associates | Canton | Ohio | 44718 | Recruiting |
| Oregon Oncology Specialists Salem | Salem | Oregon | 97301 | Recruiting |
| Avera Cancer | Sioux Falls | South Dakota | 57105 | Recruiting |
| Baylor Scott and White Research | Temple | Texas | 76502 | Recruiting |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109-1024 | Recruiting |
| MultiCare Health System Institute | Tacoma | Washington | 98405 | Recruiting |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07091019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07091019 live on ClinicalTrials.gov.